Composition for treating hyperlipidemia and atherosclerosis and application of composition
A technology of atherosclerosis and composition, which is applied in the field of biomedicine to achieve the effects of reducing drug costs, wide sources, and reducing dosage
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0030] 40 ApoE knockout mice were fed adaptively for 1 week, and the ApoE knockout mice were divided into model group, artesunate group (10 mg / kg), atorvastatin group (10 mg / kg) and compound group ( Atorvastatin: artesunate 1:1, 10mg / kg), 10 mice in each group, were given high-fat diet; apoE knockout mice were fed with high-fat diet to form an atherosclerosis model, and at the same time were given different doses according to grouping. After 2 months of treatment, blood was taken from the fundus vein of the mice, and the triglyceride and cholesterol in the serum were determined by figure 1 It can be seen that the compound group can effectively reduce the levels of cholesterol and triglyceride in mice.
[0031] Separate the aorta and observe the plaque area with oil red staining; figure 2 shown by figure 2 It can be seen that the compound group can effectively reduce the area of atherosclerotic plaque, and the effect is better than that of the atorvastatin group and the a...
Embodiment 2
[0034] Atorvastatin 10g, artesunate 10g, hypromellose 80g, polyvinylpyrrolidone 100g, lactose 85g, micronized silica gel 100g. Mix the prescribed amount of atorvastatin and artesunate with the slow-release agent (hydroxypropyl methylcellulose and lactose), add the binder polyvinylpyrrolidone plasmid, and dry at 40°C to 80°C. For dry granules, add the prescribed amount of lubricant micro-powdered silica gel to the dry granules, mix well, and punch out shaped tablets.
Embodiment 3
[0036] Atorvastatin 1g, artesunate 10g, hypromellose 80g, polyvinylpyrrolidone 100g, lactose 85g, micronized silica gel 100g. Mix the prescribed amount of atorvastatin and artesunate with the slow-release agent (hydroxypropyl methylcellulose and lactose), add the binder polyvinylpyrrolidone plasmid, and dry at 40°C to 80°C. For dry granules, add the prescribed amount of lubricant micro-powdered silica gel to the dry granules, mix well, and punch out shaped tablets.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com